ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
0,00%
Dow Jones
37 903,29
0,23%
DAX
17 932,17
-1,10%
Brent Oil
83,885
0,41%
Bitcoin
57 300,55
-1,61%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Compugen Ltd (CGEN)

  7. Compugen Ltd (CGEN) Actualités

CGEN Compugen Ltd

1,99
0,06 (3,11%)
02 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Compugen Ltd CGEN NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,06 3,11% 1,99 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,93 1,875 2,05 1,99 1,93
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
25/4/202413:00PRNUSCompugen to Present New Clinical Data Showing COM701 Triple..
10/4/202413:00PRNUSCompugen Publishes Paper in Cancer Immunology Research..
03/4/202413:00PRNUSCompugen to Participate in Two Upcoming Investor Conferences
11/3/202412:00PRNUSCompugen Selected for two Oral Presentations at the Keystone..
06/3/202413:00PRNUSCompugen to Present Data Reflecting its Diversified..
05/3/202422:06EDGAR2Form 20-F - Annual and transition report of foreign private..
05/3/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/3/202413:00PRNUSCompugen Reports Fourth Quarter and Full Year 2023 Results
05/3/202412:05IHMARKETNEWSU.S. Futures Dip, Crude Oil Fluctuates
26/2/202413:00PRNUSCompugen to Present at the Leerink Partners Global Biopharma..
20/2/202413:00PRNUSCompugen to Release Fourth Quarter and Full Year 2023..
15/2/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/2/202413:00PRNUSCompugen Announces Appointment of Michelle Mahler M.D. as..
08/1/202413:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/1/202413:05PRNUSCompugen to Receive $10 Million Milestone Payment Following..
08/1/202413:00PRNUSCompugen Regains Compliance with Nasdaq Minimum Bid Price..
19/12/202315:30APSStrong Open For Biotech Following Exclusive Agreement..
19/12/202313:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/12/202313:10PRNUSCompugen will be Eligible to Receive $10 Million Milestone..
19/12/202313:05PRNUSCompugen to Host Conference Call to Discuss Exclusive..
19/12/202313:00BWGilead and Compugen Announce Exclusive License Agreement for..
07/11/202313:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/11/202313:00PRNUSCompugen Reports Third Quarter 2023 Results
06/11/202313:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/11/202313:00PRNUSCompugen's COM701 (anti-PVRIG) Mediates Anti-Tumor Activity..
03/11/202321:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/11/202321:35PRNUSCompugen Announces Receipt of Nasdaq Minimum Bid Price..
31/10/202314:00PRNUSCompugen to Present New Data at SITC 2023 Suggesting Leading..
24/10/202313:00PRNUSCompugen to Release Third Quarter 2023 Results on Tuesday,..
03/10/202313:00PRNUSCompugen to Present at Single Cell Genomics 2023 Meeting
02/10/202313:00PRNUSCompugen Expands Intellectual Property with New Japanese..
27/9/202315:00PRNUSCompugen to Present New Clinical and Pre-Clinical Data in..
21/9/202313:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/8/202313:00PRNUSCompugen to Present at the H.C. Wainwright 25th Annual..
23/8/202314:00EDGAR2Form 20-F/A - Annual and transition report of foreign..
07/8/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/8/202313:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/8/202313:00PRNUSCompugen Reports Second Quarter 2023 Results
24/7/202313:00PRNUSCompugen to Release Second Quarter 2023 Results on Monday,..
17/7/202313:00PRNUSCompugen Wins on PVRIG European Patent Opposition Pursued by..
22/6/202313:00PRNUSCompugen Doses First Patient in Triple Immunotherapy..
13/6/202313:00PRNUSCompugen Regains Compliance with Nasdaq Minimum Bid Price..
05/6/202313:00PRNUSCompugen's COM701 (anti-PVRIG) Demonstrates Preliminary..
15/5/202313:00PRNUSCompugen Reports First Quarter 2023 Results
11/5/202313:00PRNUSCompugen to Host DNAM-1 Axis Virtual Investor Event with KOL..
09/5/202313:00PRNUSCompugen to Present at the JMP Securities Life Sciences..

Dernières Valeurs Consultées

NASDAQ
CGEN
Compugen
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés